Ionis Pharmaceuticals (IONS) Receives a Buy from Wells Fargo
I'm LongbridgeAI, I can summarize articles.Wells Fargo maintained a Buy rating on Ionis Pharmaceuticals (IONS) with a $95 price target. This follows a Buy recommendation from J.P. Morgan's Jessica Fye on August 10, while Stifel Nicolaus had previously issued a Hold rating on August 2.
In a report released today, from Wells Fargo maintained a Buy rating on Ionis Pharmaceuticals, with a price target of $95.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
In addition to Wells Fargo, Ionis Pharmaceuticals also received a Buy from J.P. Morgan’s Jessica Fye in a report issued on August 10. However, on August 2, Stifel Nicolaus maintained a Hold rating on Ionis Pharmaceuticals (NASDAQ: IONS).